Birkenstock (NYSE: BIRK) has been making podiatrist-approved sandals feel like a luxury accessory for years.
Sales keep rising, the company just raised its outlook, and a well-known contrarian investor has disclosed a sizable stake. Yet the stock has slid this year and is hovering just above its lows.